Share Search
Visit the Share Search
You are here:
OKYO Pharma to delist from LSE
4th Apr 2023 08:45
(Sharecast News) - Ophthalmology-focused bio-pharmaceutical company OKYO Pharma said on Tuesday that it has applied to delist from the London Stock Exchange.
Read moreOkyo Pharma to stagger placing into two tranches
23rd Mar 2020 09:45
(Sharecast News) - Okyo Pharma updated the market on its recently-announced placing on Monday, saying it had agreed to stagger it into two tranches.
Read moreOkyo aims to complete eye disease trials before June
23rd Jan 2019 15:45
(Sharecast News) - Okyo Pharma Limited reported on Wednesday that its preclinical studies of non-opioid painkiller BAM8 are expected to complete within the second quarter of the year.
Read moreOKYO adds experienced research director to team
21st Sep 2018 15:37
(Sharecast News) - Biotechnology company OKYO Pharma announced the appointment of Raj Patil as its senior director of research and development on Friday.
Read more